## **Core Concept**
Long-acting neuromuscular blocking agents are drugs that block the action of acetylcholine at the nicotinic receptors in the neuromuscular junction, leading to muscle paralysis. These agents have a duration of action exceeding 50-60 minutes. Examples include **pancuronium**, **tubocurarine**, and **doxacuronium**.

## **Why the Correct Answer is Right**
The correct answer, , is not a long-acting neuromuscular blocking agent because it has an intermediate duration of action. It works by blocking the nicotinic acetylcholine receptors at the neuromuscular junction but has a shorter duration of action compared to long-acting agents.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is a long-acting neuromuscular blocking agent with a prolonged duration of action, making it incorrect as an answer to this question.
* **Option B:** is also a long-acting agent, used for procedures requiring extended muscle relaxation.
* **Option D:** is another long-acting neuromuscular blocking agent.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the classification of neuromuscular blockers into short, intermediate, and long-acting categories helps in choosing the right agent for surgical procedures based on the expected duration of the surgery. For instance, **succinylcholine** is a short-acting agent often used for rapid sequence intubation.

## **Correct Answer:** .